Reference range of rivaroxaban‐calibrated anti‐Xa activity in Chinese children with giant coronary artery aneurysms after KawasakI disease: insights from a population pharmacokinetic and pharmacodynamic analysis

Ähnliche Einträge

• Percutaneous intervention of a giant native coronary artery aneurysm using self‐expanding stents
  von: Abhishek Chaturvedi, et al.
  Veröffentlicht: (2024)
• The safety, tolerability, pharmacokinetics and pharmacodynamics of GZR18 in healthy American and Chinese adult subjects
  von: Yue Liu, et al.
  Veröffentlicht: (2025)
• The pharmacokinetics/pharmacodynamics integration of tilmicosin against Mycoplasma synoviae in vitro and in vivo
  von: Xiu Yan, et al.
  Veröffentlicht: (2024)
• Extracellular vesicles as the next‐generation modulators of pharmacokinetics and pharmacodynamics of medications and their potential as adjuvant therapeutics
  von: Jiaqi Liu, et al.
  Veröffentlicht: (2024)
• Clinical study of the pharmacokinetics and pharmacodynamics of Xininurad tablets in patients with renal impairment
  von: Xiaoni Wang, et al.
  Veröffentlicht: (2025)